Opioid Consumption After Knee Arthroscopy

Not Applicable

Completed

• Conditions: Surgical Procedure, Unspecified; Orthopedic Disorder

• Registration Number: NCT03299920
• Lead Sponsor: Giorgio Veneziano

Brief Summary

This is a prospective, randomized trial of patients undergoing outpatient knee arthroscopy surgery and receiving a peripheral nerve block. Patients will be randomized to either receive standard discharge teaching or specialized teaching regarding pain control following a nerve block. Patients will be asked to complete a journal for 5 days recording their pain scores, opioid medication usage, and overall satisfaction with pain control at home.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-09-18
• Study First Submitted: 2017-09-28
• Study First Submitted QC: 2017-09-28
• Study First Posted: 2017-10-03
• Primary Completion: 2018-10-22
• Study Completion: 2018-10-28
• Status Verified: 2019-10
• Last Update Submitted: 2019-10-22
• Last Update Posted: 2019-10-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 17

Inclusion Criteria

• Patient of age less than 20 years presenting to NCH main campus for knee arthroscopy
• American Society of Anesthesiology physical status I or II

Exclusion Criteria

• Anterior cruciate ligament repair or reconstruction
• Admission to hospital
• Inability or refusal to receive femoral nerve blockade
• Body mass index > 99 percentile
• Hydrocodone allergy or intolerance
• Acetaminophen allergy or intolerance
• Non-steroidal anti-inflammatory allergy or intolerance
• Pregnancy
• Interpreter requirement
• Opioid use within 3 months prior to surgery
• Previous knee surgery at WSC after Jan. 1, 2017
• History of opioid abuse or dependence

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Number of opioid medication doses taken	Post-op day 5

Trial Locations

Locations (1)

Nationwide Children's Hospital; 🇺🇸 Columbus, Ohio, United States